Pomerantz LLP Appointed Lead Counsel in Fred's, Inc. Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit aganist Fred’s Inc.

Michael Grunfeld Honored as a Law360 Rising Star

Pomerantz is pleased to announce that Partner Michael Grunfeld, has been recognized as a Law360 Rising Star. This prestigious award is given to a select few top litigators under 40 years old “whose legal accomplishments transcend their age.”

Pomerantz LLP Appointed Lead Counsel in CBL & Associates Properties, Inc. Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities litigation class action suit against CBL & Associates Properties.

Pomerantz LLP Appointed Lead Counsel in Yang v. Nobilis Health Corp. Securities Litigation

Pomerantz LLP was appointed lead counsel in a class action lawsuit filed against Nobilis Health Corporation.

Pomerantz Achieves Settlement with Fiat Chrysler Automobiles N.V.

Pomerantz achieved a significant victory for investors in Fiat Chrysler on September 5, when U.S. District Judge Jesse M. Furman granted final approval to a $110 million settlement with the automaker. “Counsel has secured a substantial recovery for the class,” the judge said …

Pomerantz LLP Appointed Lead Counsel in Ascena Retail Group Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit against Ascena Retail Group, Inc.

Pomerantz LLP Appointed Lead Counsel in 22nd Century Group Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a class action lawsuit against 22nd Century Group on behalf of investors.

Pomerantz LLP Appointed Lead Counsel in Nabriva Therapeutics plc Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit against Nabriva Therapeutics.

Pomerantz LLP Appointed Lead Counsel in Boston Scientific Corporation Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities litigation class action against Boston Scientific Corporation.

Pomerantz LLP Appointed Lead Counsel in AT&T Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit on behalf of investors against AT&T Inc.

Pomerantz LLP Appointed Lead Counsel in Credit Suisse Securities Litigation

Pomerantz LLP was appointed Co-Lead Counsel in a class action law suit filed against Credit Suisse Group AG on behalf of investors in VelocityShares Daily Inverse VIX MediumTerm exchange-traded notes.

Pomerantz LLP Appointed Lead Counsel in CenturyLink, Inc. Securities Class Action

On June 10, 2019, Pomerantz LLP was appointed Lead Counsel in a securities class action law suit filed against CenturyLink, Inc..

Pomerantz LLP Appointed Lead Counsel in McDermott International Securities Litigation

On June 5, 2019, Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit filed against McDermott International.

Pomerantz Fights Forced Arbitration

Pomerantz’s recently filed intervention motion in a New Jersey federal court litigation marks the first court test of the legality of mandatory shareholder arbitration.

Pomerantz LLP Appointed Lead Counsel in WuXi PharmaTech (Cayman) Inc. Securities Class Action

On March 28, 2019, Pomerantz LLP was appointed Lead Counsel in a class action lawsuit against WuXi PharmaTech (Cayman) Inc. (“WuXi” or the “Company”) and certain of its officers and directors.

Pomerantz LLP Appointed Lead Counsel in CVS Health Corporation Securities Litigation

Pomerantz LLP was appointed Co-Lead Counsel in a class action law suit filed against CVS Health Corporation.

Pomerantz LLP Appointed Lead Counsel in Aveo Pharmaceuticals Securities Litigation

Pomerantz LLP was appointed lead counsel in a class action lawsuit filed against Aveo Pharmaceuticals.

Pomerantz LLP Appointed Lead Counsel in Lewis v. YRC Worldwide Inc. Securities Litigation

Pomerantz LLP was appointed lead counsel in a class action lawsuit filed against YRC Worldwide, Inc.

Pomerantz Ranked #1 in 2018 Settlements

Pomerantz LLP was ranked #1 in both Total Settlement Amount and Number of Settlements for 2018 by SCAS.

Pomerantz LLP Appointed Lead Counsel in Bellicum Pharmaceuticals Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a class action lawsuit filed against Bellicum Pharmaceuticals, Inc.